Viewing Study NCT02770508


Ignite Creation Date: 2025-12-26 @ 10:56 AM
Ignite Modification Date: 2026-01-13 @ 12:45 PM
Study NCT ID: NCT02770508
Status: COMPLETED
Last Update Posted: 2018-08-03
First Post: 2015-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Darunavir/Ritonavir + Lamivudine Versus Darunavir/Ritonavir +Emtricitabine/Tenofovir in Naïve HIV-1 Infected Subjects
Sponsor: Fundación Huésped
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module